Selective Targeting of a Maladaptive Adipokine-But Not of a Traditional Hemodynamic Phenotype-Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction.

Winrevair (sotatercept-csrk) - BMS, Merck (MSD)

Selective Targeting of a Maladaptive Adipokine-But Not of a Traditional Hemodynamic Phenotype-Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction. (PubMed, JACC Heart Fail) - Sep 10, 2026 - No abstract available
Journal • Cardiovascular • Congestive Heart Failure • Heart Failure • Hypertension • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases

http://www.ncbi.nlm.nih.gov/pubmed/42714366

Barry A Borlaug; Mardi Gomberg-Maitland; Milton Packer

Sep 10, 2026